**Core Concept**
Neoadjuvant chemotherapy refers to the administration of chemotherapeutic agents before the main treatment, which is usually surgery, to reduce the size of a tumor. This approach is used in various types of cancer to improve surgical outcomes and increase the chances of a successful resection. The goal is to make the tumor more manageable and potentially increase the patient's survival rate.

**Why the Correct Answer is Right**
Since the correct answer is not explicitly provided, let's discuss the general principle of neoadjuvant chemotherapy. It is commonly used in cancers such as breast, colon, and rectal cancer to shrink the tumor, making it easier to remove surgically. However, without knowing the specific correct answer, we can't delve into the details of why it's the right choice.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details of option A, it's challenging to provide a precise explanation for why it might be incorrect.
**Option B:** Similarly, option B's incorrectness would depend on the context of neoadjuvant chemotherapy's application.
**Option C:** Option C would be incorrect based on the diseases or conditions where neoadjuvant chemotherapy is typically not applied or is less beneficial.
**Option D:** Option D's incorrectness would hinge on the standard treatment protocols for specific cancers.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that neoadjuvant chemotherapy is selected based on the type of cancer, its stage, and the patient's overall health. It's crucial to understand which cancers are more likely to benefit from this approach.

**Correct Answer:** Correct Answer: D. Brain Tumors.